Trans-Arterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Single Tertiary Care Institute Experience

Trans-Arterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Single Tertiary Care Institute Experience

Introduction: Trans-arterial chemoembolization (TACE) is a mainstay therapeutic option indicated in early-stage non- resectable hepatocellular carcinoma (HCC) and has been shown to be associated with survival improvements. This study aimed to evaluate the radiological and clinical response of those...

Full description

Bibliographic Details
Main Authors:	Parvez Ahmed, Nasreen Naz, Amjad Sattar, Nauman al Qamari, Imtiaz Ali, Faryal Farooq, Muhammad Asadullah, Rakesh Kumar
Format:	Article
Language:	English
Published:	Shaikh Zayed Medical Complex, Lahore 2023-07-01
Series:	Proceedings
Subjects:	Hepatocellular carcinoma Trans-Arterial Chemo-embolization Chronic liver disease TACE radiological response
Online Access:	https://proceedings-szmc.org.pk/index.php/szmc/article/view/376

Similar Items

Evaluation of patients undergoing Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma with respect to tumor size, site and number of lesions
by: Amjad Sattar, et al.
Published: (2013-12-01)

Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm
by: Yashwant Patidar, et al.
Published: (2019-01-01)

Secondary Polycythemia in Hepatocellular Carcinoma: Treat or No Treat
by: Poernomo Budi Setiawan, et al.
Published: (2020-07-01)

Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update
by: Alessandro Rizzo, et al.
Published: (2022-10-01)

Transarterial Chemoembolization in Hepatocellular Carcinoma, Albanian Experience.
by: Ilirian Laçi, et al.
Published: (2022-07-01)

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients
by: Juanfang Liu, et al.
Published: (2021-10-01)

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
by: Jang JH, et al.
Published: (2015-09-01)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2020-08-01)

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
by: Yusheng Guo, et al.
Published: (2022-03-01)

Lipiodol retention pattern predicts transarterial chemoembolization therapeutic effect in hepatocellular carcinoma
by: Margaretha Vianny, et al.
Published: (2015-04-01)

Comparison of surgical resection and transcatheter arterial chemoembolization for large hepatocellular carcinoma: a systematic review and meta-analysis
by: Luke Zhou, et al.
Published: (2023-03-01)

Ischemic Stroke Post-Transradial Chemoembolization
by: Almamoon I. Justaniah, et al.
Published: (2024-01-01)

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
by: Yehyun Park, et al.
Published: (2019-04-01)

Potentiality and Boundaries of Use of Sorafenib in Patients with Hepatocellular Carcinoma: Awaiting the Results of Ongoing Clinical Trials
by: Bruno Daniele, et al.
Published: (2012-06-01)

Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
by: Jingxin Yan, et al.
Published: (2022-06-01)

EFFICACY OF INTRA-ARTERIAL LIDOCAINE FOR PAIN CONTROL RESULTING FROM TRANSARTERIAL CHEMOEMBOLIZATION OF HEPATOCELLULAR CARCINOMA
by: Ghulam Abbas, et al.
Published: (2021-06-01)

Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma
by: Sang Jung Park, et al.
Published: (2012-09-01)

Repeated TACE in HCC after Fontan surgery and situs viscerum inversus: A case report
by: Fulvio Gasparrini, M.D., et al.
Published: (2021-09-01)

Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Guoliang Shao, et al.
Published: (2022-10-01)

Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
by: Gaël S. Roth, et al.
Published: (2021-02-01)

Can triphasic hepatic multislice CT validate the LI-RADS treatment response algorithm after trans-catheter arterial chemoembolization treatment of hepatocellular carcinoma?
by: Hany El-Assaly, et al.
Published: (2023-01-01)

Transarterial chemoembolization with 125I seed insertion for multifocal hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2024-04-01)

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
by: Yi-Sheng Liu, et al.
Published: (2018-08-01)

PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
by: Sean P. Martin, et al.
Published: (2020-06-01)

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study
by: Ouyang T, et al.
Published: (2021-11-01)

A presumed pathological complete response of ruptured hepatocellular carcinoma showing retained intratumoral blood flow after trans-arterial chemo-embolization
by: Hiroshi Shintani, et al.
Published: (2023-11-01)

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study [Retraction]
by: Ouyang T, et al.
Published: (2022-01-01)

The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
by: María Pipa-Muñiz, et al.
Published: (2020-06-01)

CT-Guided 125I Brachytherapy in the Treatment of Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization: A Pilot Study
by: Xu X, et al.
Published: (2021-04-01)

Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient
by: Antonio Orlacchio, M.D., et al.
Published: (2020-12-01)

Heamodynamic Doppler changes in portal pressure after trans-arterial chemoembolization of hepatocellular carcinoma.
by: Yasmine Ali, et al.
Published: (2022-01-01)

Feasibility of Automated Volumetric Assessment of Large Hepatocellular Carcinomas' Responses to Transarterial Chemoembolization
by: Ahmed W. Moawad, et al.
Published: (2020-05-01)

Role of multislice computed tomography 3D volumetric analysis in the assessment of the therapeutic response of hepatocellular carcinoma after transarterial chemoembolization
by: Mohamed Fouad Osman, et al.
Published: (2021-07-01)

Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma
by: Seiichi Mawatari, et al.
Published: (2022-12-01)

Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry
by: Thierry de Baere, et al.
Published: (2020-11-01)

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience
by: Maen Abdelrahim, et al.
Published: (2022-01-01)

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial
by: Liang-Cheng Chen, et al.
Published: (2019-03-01)

Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study
by: Peng Guo, et al.
Published: (2022-10-01)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
by: Rong Cai, et al.
Published: (2017-11-01)

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
by: Kobayashi S, et al.
Published: (2020-10-01)